Patents by Inventor Raul San Jose Estepar

Raul San Jose Estepar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240202917
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Application
    Filed: December 5, 2023
    Publication date: June 20, 2024
    Inventors: George R. Washko, JR., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Patent number: 11869187
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Grant
    Filed: March 10, 2023
    Date of Patent: January 9, 2024
    Assignee: Johnson & Johnson Enterprise Innovation Inc.
    Inventors: George R. Washko, Jr., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Publication number: 20240005502
    Abstract: Disclosed herein are methods for determining a subject level risk of metastatic cancer involving the training and/or deployment of models to determine 1) a lymph node level risk of individual lymph node involvement and/or 2) a subject level risk of lymph node involvement. Thus, the methods can identify patients who are high or low risk for having nodal disease and optionally enable the guided intervention of cancer patients, for example, via treatment.
    Type: Application
    Filed: November 30, 2021
    Publication date: January 4, 2024
    Inventors: George R. Washko, JR., Raul San Jose Estepar, Charles Matthew Kinsey, Christopher Scott Stevenson
  • Publication number: 20230215004
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 6, 2023
    Inventors: George R. Washko, JR., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Patent number: 11640661
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 2, 2023
    Assignee: Johnson & Johnson Enterprise Innovation Inc.
    Inventors: George R. Washko, Jr., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Publication number: 20230027734
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting risk of lung cancer (e.g., current or future risk of lung cancer) for one or more subjects. Individual risk prediction models are trained on nodule-specific and non-nodule specific features, including longitudinal nodule specific and longitudinal non-nodule specific features, such that each risk prediction model can predict risk of lung cancer across different time horizons. Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Application
    Filed: July 13, 2022
    Publication date: January 26, 2023
    Inventors: George R. Washko, JR., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Publication number: 20210350935
    Abstract: Systems and methods for creating therapeutic response predictions based on a synthetic tumor model generated based on micro-scale data associated with one or more parameters representative of one or more biological characteristics of tumors, where synthetic CT images constructed via back projection of the synthetic tumor model and distribution/response of one or more therapeutic therapies predicted for the synthetic tumor model are used to train an unsupervised learning model for determining a personalized treatment plan for a patient's tumor.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 11, 2021
    Inventors: Charles Matthew Kinsey, Raul San Jose Estepar, George Washko
  • Publication number: 20210350934
    Abstract: Systems and methods for creating therapeutic response predictions based on a synthetic tumor model generated based on micro-scale data associated with one or more parameters representative of one or more biological characteristics of tumors, where synthetic CT images constructed via back projection of the synthetic tumor model and distribution/response of one or more therapeutic therapies predicted for the synthetic tumor model are used to train an unsupervised learning model for determining a personalized treatment plan for a patient's tumor.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 11, 2021
    Inventors: Charles Matthew Kinsey, Raul San Jose Estepar, George Washko
  • Publication number: 20210233241
    Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule-specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer across different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
    Type: Application
    Filed: January 15, 2021
    Publication date: July 29, 2021
    Inventors: George R. Washko, JR., Christopher Scott Stevenson, Samuel Yoffe Ash, Raul San Jose Estepar, Matthew David Mailman
  • Patent number: 9905002
    Abstract: A system for determining the prognosis of a patient suffering from pulmonary embolism is provided. The system may include at least one computer system configure to receive patient specific data regarding his pulmonary embolism status. The at least one computer system may be further configured to create a model of the patient's heart, with at least information of the two ventricles, and to determine the ratio of sizes of the ventricles. The system will then report such ratio to the clinician or report a risk index of clinical outcome for such patient.
    Type: Grant
    Filed: November 27, 2014
    Date of Patent: February 27, 2018
    Assignees: UNIVERSIDAD POLITÉCNICA DE MADRID, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, BRIGHAM AND WOMEN'S HOSPITAL
    Inventors: Germán González Serrano, Daniel Jiménez Carretero, Frank John Rybicki, María J. Ledesma Carbayo, Sara Rodríguez López, Raúl San José Estépar
  • Patent number: 8644574
    Abstract: A method for reconstructing an image includes receiving tomographic data representative of an image signal; deriving, from the image signal, a plurality of components; identifying a spatial location associated with maximum phase congruency of the components; incorporating, into an image, an edge at the spatial location; and providing an output representative of the image.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: February 4, 2014
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Raúl San José Estépar, George R. Washko, Edwin K. Silverman, John J. Reilly, Ron Kikinis, Carl-Fredrik Westin
  • Publication number: 20100172558
    Abstract: A method for reconstructing an image includes receiving tomographic data representative of an image signal; deriving, from the image signal, a plurality of components; identifying a spatial location associated with maximum phase congruency of the components; incorporating, into an image, an edge at the spatial location; and providing an output representative of the image.
    Type: Application
    Filed: October 3, 2007
    Publication date: July 8, 2010
    Applicant: THE BRIGHAM AND WOMEN S HOSPITAL, INC.
    Inventors: Raúl San José Estépar, George G. Washko, Edwin K. Silverman, John J. Reilly, Ron Kikinis, Carl-Fredrik Westin